Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEPO-Trigger Trial for Fertility Preservation in Breast Cancer
NCT04616729Phase 2Recruiting
- Sponsor
- UZ Brussel
- Start
- Nov 2022
- Primary completion
- Nov 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triptorelin in breast cancer, sponsored by UZ Brussel. Started Nov 2022; status: recruiting.
02
Drugs
triptorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04616729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04616729.